RP Management’s Cytokinetics CYTK Stock Holding History

RP Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-980,392	Closed	-$39.4M	–	3
2025 Q1	$39.4M	Hold	980,392	–	–	28.38%	2
2024 Q4	$51.8M	Hold	980,392	–	–	22.73%	2
2024 Q3	$51.8M	Hold	980,392	–	–	22.73%	2
2024 Q2	$53.1M	Buy	+980,392	New	+$59.2M	29.71%	2
2021 Q2	–	Sell	-875,656	Closed	-$20.4M	–	5
2021 Q1	$20.4M	Hold	875,656	–	–	8.33%	4
2020 Q4	$18.2M	Hold	875,656	–	–	6.09%	4
2020 Q3	$19M	Hold	875,656	–	–	2.97%	5
2020 Q2	$20.6M	Hold	875,656	–	–	4.32%	5
2020 Q1	$10.3M	Hold	875,656	–	–	3.64%	5
2019 Q4	$9.29M	Hold	875,656	–	–	2.44%	5
2019 Q3	$9.96M	Hold	875,656	–	–	6.38%	3
2019 Q2	$9.85M	Hold	875,656	–	–	6.04%	3
2019 Q1	$7.08M	Hold	875,656	–	–	3.54%	3
2018 Q4	$5.53M	Buy	+875,656	New	+$6.42M	3.79%	3

Other funds holding CYTK

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return